K872128 is an FDA 510(k) clearance for the K-GEL. Classified as Lubricant, Patient (product code KMJ), Class I - General Controls.
Submitted by Taro Pharmaceuticals, Inc. (Downsview, Ont., CA). The FDA issued a Cleared decision on June 12, 1987 after a review of 10 days - a notably fast clearance cycle.
This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.6375 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Taro Pharmaceuticals, Inc. devices